Bioaffinity Technologies Warrant Stock Alpha and Beta Analysis
| BIAFW Stock | USD 0.34 0.08 30.77% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as bioAffinity Technologies Warrant. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioAffinity Technologies over a specified time horizon. Remember, high BioAffinity Technologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioAffinity Technologies' market risk premium analysis include:
Beta 5.53 | Alpha 5.65 | Risk 22.6 | Sharpe Ratio 0.0243 | Expected Return 0.55 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BioAffinity | Build AI portfolio with BioAffinity Stock |
BioAffinity Technologies Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioAffinity Technologies market risk premium is the additional return an investor will receive from holding BioAffinity Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioAffinity Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioAffinity Technologies' performance over market.| α | 5.65 | β | 5.53 |
BioAffinity Technologies Fundamentals Vs Peers
Comparing BioAffinity Technologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioAffinity Technologies' direct or indirect competition across all of the common fundamentals between BioAffinity Technologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioAffinity Technologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioAffinity Technologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing BioAffinity Technologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioAffinity Technologies to competition |
| Fundamentals | BioAffinity Technologies | Peer Average |
| Return On Equity | -2.45 | -0.31 |
| Return On Asset | -0.72 | -0.14 |
| Profit Margin | (2.17) % | (1.27) % |
| Operating Margin | (1.59) % | (5.51) % |
| Number Of Shares Shorted | 706 | 4.71 M |
| Revenue | 9.36 M | 9.43 B |
| Gross Profit | 1.89 M | 27.38 B |
BioAffinity Technologies Opportunities
BioAffinity Technologies Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Meghji Mohsin Y of 8227 shares of BioAffinity Technologies at 2.28 subject to Rule 16b-3 | 09/19/2025 |
2 | WallachBeth Capital Announces bioAffinity Technologies Approximately 1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq R... | 10/08/2025 |
3 | Acquisition by Meghji Mohsin Y of 10245 shares of BioAffinity Technologies at 1.83 subject to Rule 16b-3 | 10/28/2025 |
4 | How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers - Interest Rate Changes Explore Stocks for Free with Our Research Portal - ulpra... | 01/07/2026 |
About BioAffinity Technologies Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioAffinity or other stocks. Alpha measures the amount that position in BioAffinity Technologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.88 | 6.06 | 5.45 | 5.73 | Days Of Inventory On Hand | 3.88 | 1.68 | 1.94 | 1.84 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioAffinity Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioAffinity Technologies' short interest history, or implied volatility extrapolated from BioAffinity Technologies options trading.
Build Portfolio with BioAffinity Technologies
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.